GeneThera, Inc.
GeneThera, Inc. (GTHR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GTHR · as of Jun 9, 2026
Key Statistics
Explore GeneThera, Inc. Data
gthr stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gthr competitorsGTHR
AHPIQ
CRXM
CRYO
DMTKQ
EPRSQStock Performance
Full HistoryAbout GeneThera, Inc.
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company…
what is genethera, inc. · gthr stock overview · genethera, inc. company profile · who is genethera, inc. ceo · gthr OTC · genethera, inc. headquarters · genethera, inc. business segments
About Stock Overview & Key Data
GeneThera, Inc. (GTHR) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 25, 2012. As of the latest trading session, GTHR stock price is $0.00, with a market capitalization of $3,533. The stock has returned -98.33% over the past 12 months and +0.00% year-to-date.
In fiscal year 2021, GeneThera, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GeneThera, Inc. (GTHR) stock price is $0.00. The stock is traded on OTC under the ticker symbol GTHR. The 52-week range is $0.00 – $0.01.